Prothegen
Latest round
- Seed
Last raised
- Nov 2021
Total raised
- Undisclosed
Investors
- 1
About Prothegen
Based in California, US, and founded in 2021, Prothegen Inc. operates as a biotechnology company. Davide Zanchi (CEO) and Scott Dixon are the co-founders of the company. The company is a developer of a biotechnology platform aimed at delivering medicines for precisely regulating cell death. It develops drugs that stop cells from dying of ferroptosis, a way how cells die.
Who invested in Prothegen
1 investor across 1 round
See all investors in Prothegen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 3, 2021
Amount
Undisclosed
Investors
Questions about Prothegen
Who invested in Prothegen?
Prothegen has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prothegen raised?
Prothegen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Prothegen last raise money?
Prothegen's most recent round on record is a Seed, in Nov 2021.
What does Prothegen do?
Based in California, US, and founded in 2021, Prothegen Inc.
Where is Prothegen headquartered?
Prothegen is headquartered in Stanford, US.
Which VCs invest in companies like Prothegen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Prothegen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Prothegen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.